Audacious Medical Grants (AMG)

The Audacious Medical Grant (AMG) is a funding tool to support medical or biomedical research projects that are original and daring but which do not find support in traditional funding channels due to a lack of preliminary data, the absence of previous work or an unusual methodology. The term “bold” means that there is a significant risk that the project will produce little or no tangible scientific results because of its innovative nature or its complexity.

 

AMG-PEDIATRICS

AMG-Pediatrics is a funding instrument supported by a private sponsor for which the FNRS uses the expertise of the SVS-4 Scientific Commission to carry out the evaluation of the submitted projects. The accumulation between the classic FNRS instruments (PDR, CDR, MIS, etc.) and the AMG-Pediatrics is authorized for filing and granting.

The AMG-Pediatrics call covers all pathologies affecting pediatric or fetal patients/subjects, including infectious diseases and vaccinology, immune deficiencies, cardiovascular, respiratory and metabolic diseases, congenital, developmental, neurological and psychiatric disorders, cancers, etc. 

  • Funding can be requested for a maximum of 24 months.
  • The maximum funding that can be requested is 120,000 euros. 

 

AMG-NEURO

The AMG-NEURO is intended for a single and eligible promoter of the Wallonia-Brussels Federation and concerns neuroscience . The submitted project must allow a better understanding of the nervous system and its pathologies and/or the development of new therapeutic avenues and/or an improvement in the prevention or detection of nervous system pathologies.   

  • The financing duration is 24 months maximum.
  • The financing amount is 120,000 euros maximum.

 

AMG-ONCO

The AMG-ONCO call is intended for a single and eligible promoter of the Wallonia-Brussels Federation and concerns all fields of the oncology . The submitted project must allow: a better understanding of the mechanisms leading to the development of cancers and/or the development of new therapeutic avenues and/or an improvement in the prevention or detection of cancers. 

  • The financing duration is 24 months maximum.
  • The financing amount is 120,000 euros maximum.

 

AMG-METABOLICS

The objective of the Audacious Medical Grant – Metabolism & Microbiome (AMG-METABOLICS) call is to support research projects at the interface between metabolism and the microbiome that are original and bold in nature, but which struggle to obtain support through traditional funding channels due to a lack of preliminary data, the absence of prior work, or the use of unconventional methodologies.

A research project is led by a Principal Investigator affiliated with a university of the Wallonia-Brussels Federation (FWB).

To be eligible as a Principal Investigator, applicants must:

  • hold a permanent F.R.S.-FNRS position as:
    • Research Associate (CQ);
    • Senior Research Associate (MR); or
    • Research Director (DR);
  • hold a Scientific Impulse Mandate – Ulysses (MISU);
  • hold a FED-tWIN mandate;
  • have a permanent or probationary appointment to an academic or scientific position within their institution.

The funding period is two years.

Applicants may request a maximum total budget of €120,000 (Personnel, Operating Costs, and Equipment).